Longitudinal toxicity analysis reveals chronic burden of cetuximab in metastatic colorectal cancer
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Longitudinal toxicity analysis reveals chronic burden of cetuximab in metastatic colorectal cancer
A pooled analysis of 1,302 patients from the ARCAD database applied a longitudinal toxicity framework to compare chemotherapy with or without cetuximab, finding that traditional single worst-grade reporting